Profile
TCRX VRTX ALNY REGN ARGX SGEN
Company Name TScan Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $99.60M $101.65B $61.42B $57.97B $46.27B $43.15B
Employees 0.20K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Gavin MacBeath Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
TCRX VRTX ALNY REGN ARGX SGEN
Quant Rating Score 2 4 1 4 4 3
Quant Rating Sell Buy Strong Sell Buy Buy Neutral
Trading
TCRX VRTX ALNY REGN ARGX SGEN
Last Close $1.69 $393.21 $461.14 $572.59 $756.83 $228.74
High 52 $5.94 $516.74 $482.13 $1153.08 $768 $228.74
Low 52 $1.1 $366.54 $224.58 $482.92 $519.76 $228.74
Price vs. 52 Week High -71.55 % -23.91 % -4.35 % -50.34 % -1.45 % 0 %
Price vs. 52 Week Low 53.64 % 7.28 % 105.33 % 18.57 % 45.61 % 0 %
Total Return
TCRX VRTX ALNY REGN ARGX SGEN
1 Month Return -6.11 % 0.11 % 2.72 % -1.35 % 15.75 % 0 %
3 Month Return 10.46 % -12.8 % 49.34 % 9.55 % 37.3 % 0 %
6 Month Return -2.87 % -22.1 % 90.74 % -14.14 % 25.1 % 0 %
9 Month Return -43.85 % -16 % 89 % -21.01 % 19.63 % 0 %
YTD Return -44.41 % -2.36 % 95.97 % -19.62 % 23.06 % 0 %
1 Year Return -70.56 % -19.66 % 70.56 % -50.34 % 40.69 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
TCRX VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -24.89 % 11.09 % -0.43 % 4.37 % -44.32 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Growth
TCRX VRTX ALNY REGN ARGX SGEN
Asset Growth 36.37 % -0.87 %
Gross Profit Growth 104.2 % 10.25 %
Revenue Growth -86.62 % 11.66 %
Revenue 3 Year -94.07 % 45.6 %
Revenue 5 Year - 163.93 %
Revenue 10 Year - 1632.15 %
EBIT Growth -44.92 % -93.69 %
Net Income Growth -42.91 % -114.8 %
Net Income 3 Yeari Growth Per Share 44.02 % -122.89 %
Net Income 5 Yeari Growth Per Share -116.63 % -145.38 %
Net Income 10 Yeari Growth Per Share -116.63 % 33.84 %
Operating Income Growth -44.26 % -106.08 %
Operating Cash Flow Growth (CFG) -80.62 % -113.93 %
Operating 3 Year CFG 51.4 % -118.65 %
Operating 5 Year CFG -97.08 % -131.3 %
Operating 10 Year CFG -97.08 % 12.43 %
EPS Growth 16.18 % -114.8 %
EPS Diluted Growth 16.18 % -114.97 %
Book Value Per Share -6.44 % -6.59 %
Share Holder 3 Year Equity Growth Per Share -68 % 62.6 %
Share Holder 5 Year Equity Growth Per Share 413.1 % 168.85 %
Share Holder 10 Year Equity Growth Per Share 413.1 % 1292.6 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth 5.35 % 116.42 %
Free Cash Flow Growth -77.74 % -124.1 %
Updated On 31 Dec 2024 31 Dec 2024
Profitability
TCRX VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM 89.79 % 86.11 % 83.64 % 81.98 % 65.32 % 79.1 %
Return on Assets TTM -45.81 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -63.84 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -53.97 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 100 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 94.83 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -2072.07 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -195.92 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Receivables Turnover TTM - 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 0.38 0.43 3.93 3.54 0.88 1.97
Inventory Turnover TTM - 1.06 5.62 0.8 2.21 0.96
Fixed Asset Turnover TTM 9.86 % 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 2.33 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -0.97 14.98 -0.12 45.13 -1.07 -2.46
Free Cash Flow Per Share TTM -1.01 13.63 -0.4 36.58 -1.09 -2.88
Cash Per Share TTM 168.08 % 3036 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -1812.71 % 33.68 % -0.63 % 33.37 % -3.31 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 104.02 % 90.99 % 335.21 % 81.05 % 102.26 % 117.04 %
Cash Flow Coverage Ratios TTM -195.92 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Price To Free Cash Flows Ratio TTM -0.76 29.05 -1179.18 15.08 -596.18 -81.26
Price To Operating Cash Flows Ratio TTM -1.81 26.46 -3910.39 12.33 -706.75 -93.1
Price Cash Flow Ratio TTM -1.81 26.46 -3910.39 12.33 -706.75 -93.1
Income Statement (TTM)
TCRX VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 100% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.12B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.13B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -1.14 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
TCRX VRTX ALNY REGN ARGX SGEN
Long Term Debt $0.09B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.13B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.24B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0.11B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0.1B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.37B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
TCRX VRTX ALNY REGN ARGX SGEN
Net Income $-0.13B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.11B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.21
AARD Aardvark Therapeutics, Inc. Common Stock 10.32
ABCL AbCellera Biologics Inc. 4.545
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.605
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.225
ABPWW 0.0316
ABSI Absci Corporation 2.645
ABUS Arbutus Biopharma Corporation 4.48
ABVC ABVC BioPharma, Inc. 2.83
ABVX Abivax SA American Depositary Shares 82.55
ACAD ACADIA Pharmaceuticals Inc. 24.07
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.8199
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.105
ACIU AC Immune SA 2.415
ETFs With Exposure to TCRX
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.0002 237.48
VTI Vanguard Total Stock Market Index Fund 0.00012 325.225
IBB iShares Biotechnology ETF 0.00824 140.96
IWN iShares Russell 2000 Value ETF 0.00015 174.62
IWV iShares Russell 3000 ETF 0.00002 374.47
IWO iShares Russell 2000 Growth ETF 0.00025 312.385
BIB ProShares Ultra Nasdaq Biotechnology 0.00565942 56.59
VXF Vanguard Extended Market Index Fund 0.00108 208.435
HDG ProShares Hedge Replication ETF 0.00030009 51.185
UWM ProShares Ultra Russell2000 0.00174599 45.015
VTHR Vanguard Russell 3000 Index Fund 0 291.59
IWC iShares Micro-Cap ETF 0.01845 145.58
DWAS Invesco DWA SmallCap Momentum ETF 0.245 89.295
URTY ProShares UltraPro Russell2000 0.00139667 50.64
VTWV Vanguard Russell 2000 Value Index Fund 0.00166 154.67
GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF 0 74.525
VTWG Vanguard Russell 2000 Growth Index Fund 0.0028 228.54
VTWO Vanguard Russell 2000 Index Fund 0.00216 96.34
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 45.37
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00017 110.81
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 110.79
VBAIX Vanguard Balanced Index Fund Institutional Shares 0.00008 52.49
VBIAX Vanguard Balanced Index Fund Admiral Shares 0.00008 52.48
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.48
BMED BlackRock Future Health ETF 0.09341 26.1896
DFAU Dimensional US Core Equity Market ETF 0.00006011 45.335
IBBQ Invesco Nasdaq Biotechnology ETF 0.009 23.74
DFUS Dimensional U.S. Equity ETF 0.00002438 71.765
DFAT Dimensional U.S. Targeted Value ETF 0.00006975 58.52
DFAS Dimensional U.S. Small Cap ETF 0.00005199 68.22
DFAC Dimensional U.S. Core Equity 2 ETF 0.00009816 38.255
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.00779 5.826
VTSAX Vanguard Total Stock Market Index Fund 0 158.59
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.00779 6.905
SBIO.MI Invesco NASDAQ Biotech UCITS ETF 0.0092 41.615
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00108 158.85
VITSX Vanguard Total Stock Market Index Fund 0 158.62
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.00779 6.871
SBIO.L Invesco NASDAQ Biotech UCITS ETF 0.0092 49.27
DFSU Dimensional US Sustainability Core 1 ETF 0.00060449 42.075
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000809312 16.02
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00108 158.86
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.00779 5.0525
AVSC Avantis U.S. Small Cap Equity ETF 0 57.075
SURI Simplify Propel Opportunities ETF 2.6255 15.71
VTS.AX Vanguard US Total Market Shares Index ETF 0.00012 489.43
DCOR Dimensional ETF Trust 0.00050691 71.41
VEMPX Vanguard Extended Market Index InstlPlus 0.00108 392.02
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00012 297.56
RSSL Global X Funds 0 93.535
DXUV Dimensional ETF Trust 0.00003069 58.08
RFLR Innovator ETFs Trust 0.02 27.325
Unlock